• About us
• Contact

Advertisement

Organisation › Details

C.B.S. Scientific Company

For over 40 years, C.B.S. SCIENTIFIC has been dedicated to excellence in manufacturing Electrophoresis Equipment and Scientific Instruments. Every product is engineered for versatility, optimal performance and ease of use. A wide variety of products and unsurpassed selection of accessories allow the researcher to perform existing applications or easily adapt to changing methodologies. Our innovative designs, problem-solving expertise and high standard of quality in manufacturing has provided us with many unique opportunities. C.B.S. SCIENTIFIC is the primary supplier of critical components to some of the world leaders in automated laboratory technology and the O.E.M. manufacturer for some of the most respected scientific distributors worldwide. C.B.S. SCIENTIFIC continues to enjoy collaborations with scientists to develop new products or improve existing ones. *

 

	Start	1975-01-01 established (approx)
	Group	2invest (Group)
	Industry	contract manufacturing (laboratory equipment and instruments)
	Industry 2	electrophoresis
	Region	San Diego, CA
	Country	United States (USA)
	Street	10805 Vista Sorrento Parkway Suite 100
	City	92121 San Diego, CA
	Tel	+1-858-755-4959
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	1,500,000 (revenues, expected (2016) 2016-12-31)
		�About Section� taken from web site of organisation on 02.02.
		Record changed: 2023-07-10

Advertisement

More documents for 2invest (Group)

• [1] 4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge....
• [2] Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge....
• [3] Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge....
• [4] Sygnis AG. (5/8/18). "Press Release: Sygnis Completes Acquisition of TGR Biosciences". Heidelberg & Cambridge....
• [5] Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg....
• [6] Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg....
• [7] Sygnis AG. (6/6/17). "Press Release: Sygnis AG Announces Management and Supervisory Board Changes. Dr. Heikki Lanckriet Sole CEO". Madrid & Heidelberg....
• [8] Sygnis AG. (5/8/17). "Press Release: Sygnis AG Plans to Acquire Profitable Innova Biosciences Ltd. for EUR 8 Million in Cash and up to 3.5 Million Shares [Not for USA, Canada, Japan and Australia]". Madrid & Heidelberg....
• [9] Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg....
• [10] Sygnis AG. (4/24/17). "Press Release: Sygnis AG Expands Access to Chinese Market with Second OEM Deal with Tanon". Madrid & Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.